Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.74

€1.74

-1.140%
-0.02
-1.140%
-
 
27.03.24 / Tradegate WKN: A2DY0D / Symbol: CVM / Name: CEL-SCI / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

CEL-SCI Corp. Stock

A loss of -1.140% shows a downward development for CEL-SCI Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for CEL-SCI Corp. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of CEL-SCI Corp. in the next few years

Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of CEL-SCI Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
CEL-SCI Corp. -1.140% -7.937% -6.952% -16.507% -32.558% -87.686% -
Celsion Corp. 8.040% 47.059% 121.239% 1.626% 70.068% -94.331% -
India Globalization Capital -0.610% 9.396% 9.396% 16.679% 24.427% -76.964% -82.473%
BioInvent International AB -0.960% 2.104% 1.961% -39.079% -11.220% -68.154% -57.797%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-11-02

Geben Sie mir eine kurze allgemeine Bewertung der finanziellen Lage des Unternehmens CEL-SCI.

Ein genauer Blick auf die finanziellen Kennzahlen weist auf mehrere ausschlaggebende Punkte hin. Erstens, es ist zu beachten, dass CEL-SCI Corporation (CVM) eine Kapitalisierung von rund $96,1 Millionen aufweist. Das projizierte Kurs-Gewinn-Verhältnis (P/E Ratio) ist nicht verfügbar, was auf fehlende Gewinne hindeutet. In der Tat sind die Gewinne pro Aktie (EPS) negativ bei -0,74 und die bereinigte Gewinnspanne liegt bei null. Dies zeigt, dass das Unternehmen zurzeit kein Geld verdient.

Des Weiteren liegt das Buchwert-Pro-Kopf bei 0,331, was relativ gering ist. Dementsprechend gibt das Unternehmen keine Dividenden aus und es fehlt an marktorientierten Rentabilitätskennzahlen wie Rendite auf Eigenkapital (ROE) und Rendite auf Vermögenswerte (ROA), die beide negativ sind. Es zeigt, dass das Unternehmen in finanzieller Hinsicht wohl mit einigen Herausforderungen zu kämpfen hat.

Comments

CEL-SCI Co. (NYSE: CVM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CVM provided by MarketBeat
Show more

CEL-SCI Co. (NYSE: CVM) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CVM provided by MarketBeat
Show more

CEL-SCI Co. (NYSE: CVM) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CVM provided by MarketBeat
Show more